Ticker: SPRO

Class Period Start: 10/28/2021

Class Period End: 05/02/2022

Registration Deadline: 07/25/2022

A securities class action has been filed in the USDC, E.D.N.Y. against Spero Therapeutics, Inc. (SPRO) on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Spero securities between October 28, 2021 through May 2, 2022. 

The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects.  Specifically, Defendants made false and/or misleading statements  and/or failed to disclose that:

  • the data submitted  in support of the Tebipenem HBr NDA were insufficient to obtain FDA approval;
  • accordingly, it was unlikely that the FDA would approve the Tebipenem HBr NDA in its current form;
  • the foregoing  would  necessitate  a  significant  workforce  reduction  and  restructuring  of  Spero’s operations;  and
  • as  a  result,  the  Company’s public  statements  were  materially  false  and misleading at all relevant times.

If you suffered a loss on your investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.

An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.

Purchases

Sales

Please Note

Neither the submission to nor the receipt of information by Lowey Dannenberg or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

* Indicates a required field.

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.